Wintermute Biomedical is an antimicrobials-focused pharmaceutical company located in Melbourne, Australia and Missoula, Montana. We have developed a novel platform for harnessing the antimicrobial activity of fatty acids, with a focus on developing a next-generation treatment for Shingles. Our lead product Solexan™ is now in clinical trials. Our vision is to make Solexan™ available for the millions of people who fall victim to Shingles each year.
Company Details
- Employees
- 7
- Address
- Melbourne, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- wintermutebiomedical.com
- Keywords
- IT Consulting.
- HQ
- Melbourne
Wintermute Biomedical Pty Ltd Questions
Wintermute Biomedical Pty Ltd's website is wintermutebiomedical.com
Wintermute Biomedical Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/wintermutebiomedical
Wintermute Biomedical Pty Ltd has
7 employees.
View email and phone details for 7
employees at Wintermute Biomedical Pty Ltd.
Wintermute Biomedical Pty Ltd's industry is
Biotechnology Research
Wintermute Biomedical Pty Ltd's top competitors are
Purdue Chemistry,
Sapro Cro,
Pharmsky Research,
Fyr Bio,
Protinhi Therapeutics,
Momentum Clinical Research,
Asha Therapeutics,
Lisam Australia Pty Ltd,
Rocky Mountain Biologicals, Llc,
Benevira.
Wintermute Biomedical Pty Ltd's categories are Biotechnology Research
